Chemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis

Pathology and Oncology Research

Volumn 19, Issue 2, 2013, Pages 287-296

  Sulfikkarali, Nechikkad ^a   Krishnakumar, Narendran ^a   Manoharan, Shanmugam ^a   Nirmal, Ramadas Madhavan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

DMBA; Hamster buccal pouch carcinogenesis; Nanochemoprevention; Naringenin

Indexed keywords

CYCLINE; EUDRAGIT; NANOPARTICLE; NARINGENIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTILIPID PEROXIDATIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER MORPHOLOGY; CANCER PREVENTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DYSPLASIA; EXPERIMENTAL NEOPLASM; HISTOPATHOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LIGHT SCATTERING; LIPID PEROXIDATION; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; SYRIAN HAMSTER; TRANSMISSION ELECTRON MICROSCOPY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTIOXIDANTS; CARCINOGENESIS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CHEEK; CHEMOPREVENTION; CRICETINAE; FLAVANONES; LIPID PEROXIDATION; MALE; MESOCRICETUS; MOUTH MUCOSA; MOUTH NEOPLASMS; NANOPARTICLES; PARTICLE SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880114929     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-012-9581-1     Document Type: Article

References (35)

1. Warnakulasurya S (2010) Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes the influence survival. Oral Oncol 46:407-410
2. Nagini S (2009) Of human and hamsters: the hamster buccal pouch carcinogenesis model as a paradigm for oral carcinogenesis and chemoprevention. Anti Cancer Agents Med Chem 9:843-852
3. Dipple A, Piggot M, Moschel RC, Constantino N (1983) Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Can Res 43:4132-4135
4. Shklar G (1999) Development of experimental oral carcinogenesis and its impact on current oral cancer research. J Dent Res 78:1768-1772
5. Nagini S, Vidjaya Letchoumy P, Thangavelu A, Ramachandran CR (2009) Of humans and hamsters: a comparative evaluation of carcinogen activation, DNA damage, cell proliferation apoptosis, invasive and angiogenesis in oral cancer patients and hamster buccal pouch carcinomas. Oral Oncol 45:31-37
6. Harish kumar G, Vidya priyadarsini R, Vinothini G et al (2010) The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Invest New Drugs 28:392-401
7. Amaro MI, Helder Vila-Real JR, Eduardo-Figueira M et al (2009) Anti-inflammatory activity of naringin and biosynthesised naringenin by naringinase immomobilized in microstructured materials in a model of DDS-induced colitis in mice. Food Res Int 42:1010-1017
8. Choi JS, Park KY, Moon SH, Rhee SH et al (1994) Antimutagenic effect of plant flavonoids in the salmonella assay system. Arch Pharm Res 17:71-75
9. Lee CH, Jeong TS, Choi YK et al (2001) Antiatherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aorticVCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biophys Res Commun 284:681-688
10. Ekambaram G, Rajendran P, Magesh V, Sakthisekaran D (2008) Naringenin reduces tumor size and weight loss in N-methyl-N-nitro-N-nitrosoguanidine- induced gastric carcinogenesis in rats. Nutr Res 28:106-112
11. 4-induced acute liver failure. Pharm Res 26:893-902
12. Wen J, Liu B, Yuan E, Ma Y et al (2010) Preperation and physicochemical properties of the complex of naringenin with hydroxypropyl-β-cyclodextrin. Molecules 15:4401-4447
13. Semalty A, Semalty M, Singh D, Rawat MSM (2010) Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 67:253-260
14. Krishnakumar N, Sulfikkarali N, Rajendra Prasad N, Karthikeyan S (2011) Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomed Prev Nutr 1:223-231
15. Alonso JM (2004) Nanomedicines for overcoming biological barriers. Biomed Pharmacother 58:168-172
16. Siddiqui IA, Adhami VM, Bharali DJ et al (2009) Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res 69:712-716
17. Okhawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
18. Beutler E, Kelly BM (1963) The effect of sodium nitrite on red cell GSH. Experientia 19:96-97
19. Rotruck JT, Pope AL, Ganther HE et al (1973) Selenium: biochemical role as component of gluthaione peroxidase. Science 179:588-599
20. Kakkar P, Das B, Viswanathan PN (1984) A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21:130-132
21. Sinha AK (1972) Calorimetric assay of catalase. Anal Biochem 47:389-394
22. Palan PR, Mikhail MS, Basu J, Romney SL (1991) Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 15:13-20
23. Panjamurthy K, Manoharan S, Nirmal MR, Vellaichamy L (2009) Protective role of Withaferin-A on immuno expression of p53 and bcl-2 in 7, 12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis. Invest New Drugs 27:447-452
24. Lyzogubov V, Khozhaenko Y, Usenko V et al (2008) Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer. Exp Oncol 27:141-144
25. Acharya SDF, Sahoo SK (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30:5737-5750
26. Manoharan S, Vasanthaselvan M, Silvan S et al (2010) Carnosic acid: A potent chemopreventive agent against oral carcinogenesis. Chem Bio Inter 188:616-622
27. Krishnakumar N, Manoharan S, Palaniappan PLRM (2009) Chemopreventive efficacy of piperine in 7,12-dimethylbenz(a)anthrazene(DMBA)-induced hamster buccal pouch carcinogenesis: an FT-IR study. Food Chem Toxicol 47:2813-2820
28. Wu G, Fang YZ, Yang S et al (2004) Glutathione metabolism and its implication for health. J Nutr 134:489-492
29. Silvan S, Manoharan S, Baskaran N et al (2011) Chemopreventive potential of apigenin in 7, 12-dimethylbenz (a)anthracene induced experimental oral carcinogenices. Eur J Pharmcol 670:571-577
30. McCormik D, Hall PA (1992) The complexities of proliferating cell nuclear antigen. Histopathology 21:591-594
31. Shin DM, Voravud N, Ro JY et al (1993) Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J Natl Cancer Int 85:971-978
32. Chans KW, Sarraj S, Lin SS et al (2000) P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 21:1441-1451
33. Das N, Sahoo SK (2011) Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy. Acta Biomaterialia 7:355-369
34. Mohanty C, Sahoo SK (2010) The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 3:6597-6611
35. Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumor delivery by EPR effect. Adv Drug Del 63:170-183